Update of the mechanism and characteristics of tuberculosis in chronic kidney disease: Review article
Summary The risk of tuberculosis (TB) is significantly increased in patients with chronic kidney disease (CKD), which is closely related to hyperparathyroidism, malnutrition and oxidative stress as well as immune deficiency in patients with end-stage renal disease (ESRD). Vitamin D deficiency and ge...
Gespeichert in:
| Veröffentlicht in: | Wiener Klinische Wochenschrift 2022-07, Vol.134 (13-14), p.501-510 |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 510 |
|---|---|
| container_issue | 13-14 |
| container_start_page | 501 |
| container_title | Wiener Klinische Wochenschrift |
| container_volume | 134 |
| creator | Zhang, Xuehan Chen, Pingshan Xu, Gaosi |
| description | Summary
The risk of tuberculosis (TB) is significantly increased in patients with chronic kidney disease (CKD), which is closely related to hyperparathyroidism, malnutrition and oxidative stress as well as immune deficiency in patients with end-stage renal disease (ESRD). Vitamin D deficiency and gender bias are independent risk factors. In the TB screening and diagnosis test of CKD, interferon-gamma release assays (IGRA), including T‑SPOT.TB test (T-SPOT) and QuantiFERON-TB Gold In-Tube (QFT-GIT) have been available. Many studies have found that they are more sensitive and specific than tuberculin skin test (TST). At present, IGRA has been used to study various types of immunocompromised patients. For CKD patients with TB, the choice and dosage of anti-TB drugs need to be reconsidered. Weekly treatment with rifapentin (RFT) and isoniazid (INH) for 3 months is an effective treatment for latent tuberculosis infection (LTBI) in hemodialysis (HD) patients. Therefore, in this review we discuss CKD and TB, its pathogenesis, clinical features, diagnosis and treatment advancements. |
| doi_str_mv | 10.1007/s00508-022-02009-y |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2636869735</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2636869735</sourcerecordid><originalsourceid>FETCH-LOGICAL-c298t-625f74e5a3c2f3ea882d74a10c3181e8eae5b7eaea7d3268c349cbaf31ba77023</originalsourceid><addsrcrecordid>eNp9kD1PwzAURS0EoqXwBxhQRpaAP-LYGVHFl1SJhc6W47xQlyYpfsmQf49pCiOD7Se9c6_kQ8g1o3eMUnWPlEqqU8p5PJQW6XhC5ixnIlW5YqdkTmkmUim4nJELxC2lQmaKnZOZkFxmUsg5Wa_3le0h6eqk30DSgNvY1mOT2LZK4hys6yF47L3DAzSUENyw69Bj4tuIhK71Lvn0VQtjUnkEi3BJzmq7Q7g6vguyfnp8X76kq7fn1-XDKnW80H2ac1mrDKQVjtcCrNa8Upll1AmmGWiwIEsVb6sqwXPtRFa40taClVYpysWC3E69-9B9DYC9aTw62O1sC92Ahuci13mhhIwon1AXOsQAtdkH39gwGkbNj04z6TRRpznoNGMM3Rz7h7KB6i_y6y8CYgIwrtoPCGbbDaGNf_6v9hsjm4HM</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2636869735</pqid></control><display><type>article</type><title>Update of the mechanism and characteristics of tuberculosis in chronic kidney disease: Review article</title><source>SpringerLink Journals</source><creator>Zhang, Xuehan ; Chen, Pingshan ; Xu, Gaosi</creator><creatorcontrib>Zhang, Xuehan ; Chen, Pingshan ; Xu, Gaosi</creatorcontrib><description>Summary
The risk of tuberculosis (TB) is significantly increased in patients with chronic kidney disease (CKD), which is closely related to hyperparathyroidism, malnutrition and oxidative stress as well as immune deficiency in patients with end-stage renal disease (ESRD). Vitamin D deficiency and gender bias are independent risk factors. In the TB screening and diagnosis test of CKD, interferon-gamma release assays (IGRA), including T‑SPOT.TB test (T-SPOT) and QuantiFERON-TB Gold In-Tube (QFT-GIT) have been available. Many studies have found that they are more sensitive and specific than tuberculin skin test (TST). At present, IGRA has been used to study various types of immunocompromised patients. For CKD patients with TB, the choice and dosage of anti-TB drugs need to be reconsidered. Weekly treatment with rifapentin (RFT) and isoniazid (INH) for 3 months is an effective treatment for latent tuberculosis infection (LTBI) in hemodialysis (HD) patients. Therefore, in this review we discuss CKD and TB, its pathogenesis, clinical features, diagnosis and treatment advancements.</description><identifier>ISSN: 0043-5325</identifier><identifier>EISSN: 1613-7671</identifier><identifier>DOI: 10.1007/s00508-022-02009-y</identifier><identifier>PMID: 35254535</identifier><language>eng</language><publisher>Vienna: Springer Vienna</publisher><subject>Endocrinology ; Gastroenterology ; Internal Medicine ; Medicine ; Medicine & Public Health ; Pneumology/Respiratory System ; Review Article</subject><ispartof>Wiener Klinische Wochenschrift, 2022-07, Vol.134 (13-14), p.501-510</ispartof><rights>The Author(s), under exclusive licence to Springer-Verlag GmbH Austria, part of Springer Nature 2022</rights><rights>2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Austria, part of Springer Nature.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c298t-625f74e5a3c2f3ea882d74a10c3181e8eae5b7eaea7d3268c349cbaf31ba77023</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s00508-022-02009-y$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s00508-022-02009-y$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,780,784,27924,27925,41488,42557,51319</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35254535$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Zhang, Xuehan</creatorcontrib><creatorcontrib>Chen, Pingshan</creatorcontrib><creatorcontrib>Xu, Gaosi</creatorcontrib><title>Update of the mechanism and characteristics of tuberculosis in chronic kidney disease: Review article</title><title>Wiener Klinische Wochenschrift</title><addtitle>Wien Klin Wochenschr</addtitle><addtitle>Wien Klin Wochenschr</addtitle><description>Summary
The risk of tuberculosis (TB) is significantly increased in patients with chronic kidney disease (CKD), which is closely related to hyperparathyroidism, malnutrition and oxidative stress as well as immune deficiency in patients with end-stage renal disease (ESRD). Vitamin D deficiency and gender bias are independent risk factors. In the TB screening and diagnosis test of CKD, interferon-gamma release assays (IGRA), including T‑SPOT.TB test (T-SPOT) and QuantiFERON-TB Gold In-Tube (QFT-GIT) have been available. Many studies have found that they are more sensitive and specific than tuberculin skin test (TST). At present, IGRA has been used to study various types of immunocompromised patients. For CKD patients with TB, the choice and dosage of anti-TB drugs need to be reconsidered. Weekly treatment with rifapentin (RFT) and isoniazid (INH) for 3 months is an effective treatment for latent tuberculosis infection (LTBI) in hemodialysis (HD) patients. Therefore, in this review we discuss CKD and TB, its pathogenesis, clinical features, diagnosis and treatment advancements.</description><subject>Endocrinology</subject><subject>Gastroenterology</subject><subject>Internal Medicine</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Pneumology/Respiratory System</subject><subject>Review Article</subject><issn>0043-5325</issn><issn>1613-7671</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNp9kD1PwzAURS0EoqXwBxhQRpaAP-LYGVHFl1SJhc6W47xQlyYpfsmQf49pCiOD7Se9c6_kQ8g1o3eMUnWPlEqqU8p5PJQW6XhC5ixnIlW5YqdkTmkmUim4nJELxC2lQmaKnZOZkFxmUsg5Wa_3le0h6eqk30DSgNvY1mOT2LZK4hys6yF47L3DAzSUENyw69Bj4tuIhK71Lvn0VQtjUnkEi3BJzmq7Q7g6vguyfnp8X76kq7fn1-XDKnW80H2ac1mrDKQVjtcCrNa8Upll1AmmGWiwIEsVb6sqwXPtRFa40taClVYpysWC3E69-9B9DYC9aTw62O1sC92Ahuci13mhhIwon1AXOsQAtdkH39gwGkbNj04z6TRRpznoNGMM3Rz7h7KB6i_y6y8CYgIwrtoPCGbbDaGNf_6v9hsjm4HM</recordid><startdate>20220701</startdate><enddate>20220701</enddate><creator>Zhang, Xuehan</creator><creator>Chen, Pingshan</creator><creator>Xu, Gaosi</creator><general>Springer Vienna</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20220701</creationdate><title>Update of the mechanism and characteristics of tuberculosis in chronic kidney disease</title><author>Zhang, Xuehan ; Chen, Pingshan ; Xu, Gaosi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c298t-625f74e5a3c2f3ea882d74a10c3181e8eae5b7eaea7d3268c349cbaf31ba77023</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Endocrinology</topic><topic>Gastroenterology</topic><topic>Internal Medicine</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Pneumology/Respiratory System</topic><topic>Review Article</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Zhang, Xuehan</creatorcontrib><creatorcontrib>Chen, Pingshan</creatorcontrib><creatorcontrib>Xu, Gaosi</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Wiener Klinische Wochenschrift</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Zhang, Xuehan</au><au>Chen, Pingshan</au><au>Xu, Gaosi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Update of the mechanism and characteristics of tuberculosis in chronic kidney disease: Review article</atitle><jtitle>Wiener Klinische Wochenschrift</jtitle><stitle>Wien Klin Wochenschr</stitle><addtitle>Wien Klin Wochenschr</addtitle><date>2022-07-01</date><risdate>2022</risdate><volume>134</volume><issue>13-14</issue><spage>501</spage><epage>510</epage><pages>501-510</pages><issn>0043-5325</issn><eissn>1613-7671</eissn><abstract>Summary
The risk of tuberculosis (TB) is significantly increased in patients with chronic kidney disease (CKD), which is closely related to hyperparathyroidism, malnutrition and oxidative stress as well as immune deficiency in patients with end-stage renal disease (ESRD). Vitamin D deficiency and gender bias are independent risk factors. In the TB screening and diagnosis test of CKD, interferon-gamma release assays (IGRA), including T‑SPOT.TB test (T-SPOT) and QuantiFERON-TB Gold In-Tube (QFT-GIT) have been available. Many studies have found that they are more sensitive and specific than tuberculin skin test (TST). At present, IGRA has been used to study various types of immunocompromised patients. For CKD patients with TB, the choice and dosage of anti-TB drugs need to be reconsidered. Weekly treatment with rifapentin (RFT) and isoniazid (INH) for 3 months is an effective treatment for latent tuberculosis infection (LTBI) in hemodialysis (HD) patients. Therefore, in this review we discuss CKD and TB, its pathogenesis, clinical features, diagnosis and treatment advancements.</abstract><cop>Vienna</cop><pub>Springer Vienna</pub><pmid>35254535</pmid><doi>10.1007/s00508-022-02009-y</doi><tpages>10</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0043-5325 |
| ispartof | Wiener Klinische Wochenschrift, 2022-07, Vol.134 (13-14), p.501-510 |
| issn | 0043-5325 1613-7671 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2636869735 |
| source | SpringerLink Journals |
| subjects | Endocrinology Gastroenterology Internal Medicine Medicine Medicine & Public Health Pneumology/Respiratory System Review Article |
| title | Update of the mechanism and characteristics of tuberculosis in chronic kidney disease: Review article |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T07%3A00%3A34IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Update%20of%20the%20mechanism%20and%20characteristics%20of%20tuberculosis%20in%20chronic%20kidney%20disease:%20Review%20article&rft.jtitle=Wiener%20Klinische%20Wochenschrift&rft.au=Zhang,%20Xuehan&rft.date=2022-07-01&rft.volume=134&rft.issue=13-14&rft.spage=501&rft.epage=510&rft.pages=501-510&rft.issn=0043-5325&rft.eissn=1613-7671&rft_id=info:doi/10.1007/s00508-022-02009-y&rft_dat=%3Cproquest_cross%3E2636869735%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2636869735&rft_id=info:pmid/35254535&rfr_iscdi=true |